Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Ado-Trastuzumab Emtansine × Clear all

NCT02999672 2019-08-28

KAMELEON

Phase 2 Completed

20 enrolled 14 charts

GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma